Cyfuse Biomedical K.K. Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

4892

Rank in Stocks #24413
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K.... Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Share Price
$3.21
Last synced: 2026-11-13
Market Cap
$32.36M
Change (1 day)
-2.22%
Change (1 year)
-13.07%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Cyfuse Biomedical K.K. (4892)
Operating Margin as of November 2026 TTM: -253.17%
According to Cyfuse Biomedical K.K.'s latest financial reports, its current operating margin (TTM) is -253.17%. At the end of 2025 the company had an operating margin of -358.52%.
Operating Margin history for Cyfuse Biomedical K.K. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -253.17% -29.38%
2025 -358.52% -78.22%
2024 -1,645.91% 44.22%
2023 -1,141.24% 905.32%
2022 -113.52% -1,239.76%
2021 9.96% -103.68%
2020 -270.68% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.23%
US
33.87% -100.13%
US
-116.04% -99.54%
US
25.57% -100.10%
AU
31.23% -100.12%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Cyfuse Biomedical K.K.'s operating margin

What is Cyfuse Biomedical K.K.'s operating margin?

Cyfuse Biomedical K.K.'s operating margin is -253.17%, as of Nov 2026.

What was Cyfuse Biomedical K.K.'s operating margin in 2025?

In 2025, Cyfuse Biomedical K.K.'s operating margin was -358.52%, compared with -1,645.91% in 2024.

How has Cyfuse Biomedical K.K.'s operating margin changed since 2020?

From 2020 to 2025, Cyfuse Biomedical K.K.'s operating margin was highest in 2021 (9.96%) and lowest in 2024 (-1,645.91%).

How does Cyfuse Biomedical K.K.'s operating margin compare with similar companies?

Cyfuse Biomedical K.K.'s operating margin (-253.17%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.